IGM Biosciences, Inc.

Historical 13F Holders

Symbol
IGMS
CUSIP
449585108
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 449585108 since 12/18/2024, largest first.

Filer % of Class Filed
Price T Rowe Associates Inc /MD/ 13G/A 10.5% 2/14/2025
Event 12/31/2024
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Baker Bros. Advisors LP 13D/A
0% 8/18/2025
Event 8/14/2025
Glazer Capital, LLC 13G/A
0% 11/13/2025
Event 9/30/2025
Redmile Group, LLC 13D/A
0% 8/15/2025
Event 8/14/2025
Topsoe Holding A/S 13D/A
0% 8/18/2025
Event 8/14/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q3 1 400 $508
2025 Q2 67 15.9 M $17.9M
2025 Q1 81 17.8 M $20.5M
2024 Q4 87 21.7 M $133M
2024 Q3 74 21.6 M $357M
2024 Q2 84 22.3 M $153M
2024 Q1 88 22.8 M $220M
2023 Q4 73 21.9 M $182M
2023 Q3 80 22.3 M $186M
2023 Q2 81 22.3 M $208M
2023 Q1 78 17.9 M $245M
2022 Q4 83 18.0 M $306M
2022 Q3 95 17.7 M $402M
2022 Q2 92 17.5 M $316M
2022 Q1 98 18.2 M $487M
2021 Q4 91 17.6 M $517M
2021 Q3 110 16.9 M $1.11B
2021 Q2 110 16.3 M $1.36B
2021 Q1 115 18.0 M $1.38B
2020 Q4 114 17.2 M $1.52B
2020 Q3 97 14.7 M $1.08B
2020 Q2 83 14.0 M $1.02B
2020 Q1 63 13.3 M $742M
2019 Q4 51 12.2 M $463M
2019 Q3 34 10.0 M $178M